Principal Investigator:
Duancheng Wen, Assistant Professor of Reproductive Medicine Research in Obstetrics and Gynecology
Background & Unmet Need
- Cell culture media are vital for the maintenance and derivation of stem cells
- Current state of the art cell culture media, two inhibitor/LIF (2i/LIF), do not enable long term culture of murine embryonic stem cells (mESCs)
- Prolonged culture of mESCs in current media compositions result in aneuploidy, lost DNA methylation, impaired developmental potential, and the inability to derive fully potent female mESCs
- Unmet Need: A serum-free mESC 2i/LIF cell culture media that maintains the genomic stability and developmental potency of mESCs over long term culture
Technology Overview
- The Technology: Novel serum-free cell culture media that improves genomic stability and promotes full potency in mESCs, and the mESCs that are derived using it
- The Discovery: Lipid supplementation to 2i/LIF cell culture media results positive long term culture outcomes in mESCs
- PoC Data: This media reduces the incidence of abnormal numbers of chromosomes, preserves DNA methylation, maintains mESC developmental potential, and allows the derivation of fully potent female mESCs through preservation of X-chromosomes beyond 40 cell passages
- mESCs cultured in this media can be used to produce fertile all-ESC adults, providing a platform that is readily available for the development of specific genetic lines for R&D of various therapeutics
Technology Applications
- mESC expansion and differentiation for cell therapeutics
- mESC differentiation into organoids for pharmaceutical development and testing
- Genetic manipulation of mESC lines and mouse model constructs for pharmaceutical development and testing
Technology Advantages
- Promotes long term genomic stability and full potency maintenance for mESCs in both sexes and non-permissive strains
- Supports de novo derivation of mESCs from both male and female blastocysts
- Maintains mESCs in naive or formative pluripotent states
Resources
Intellectual Property
Patents
- Provisional Filed
Cornell Reference
- 10417
Contact Information

For additional information please contact
Donna Rounds
Associate Director, Business Development and Licensing
Phone: (646) 962-7044
Email: djr296@cornell.edu